Brind.

Reciprocal tariffs increased import levies while stock slumps were reported following earnings releases and disappointing biotech trial results.

Disappointing drug data and narrowed revenue forecasts caused stock declines for Eli Lilly and cybersecurity stocks.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Disappointing drug data and narrowed revenue forecasts caused stock declines for Eli Lilly and cybersecurity stocks.

Who's involved

What this event is mainly about

Fortinet Eli Lilly and Company

Keep exploring

Part of

Reciprocal tariffs increased import levies while stock slumps were reported following earnings releases and disappointing biotech trial results. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped

Aug 8BarchartStocks Close Mixed after Higher Bond Yields and Tariff News The S&P 500 Index ($SPX) (SPY) Thursday closed down -0.08%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.51%, and the Nasda